Page 2 - Mylan

US FDA warns Mylan over quality concerns at India facility

US FDA's concerns stem from an inspection in September of a facility located in Maharashtra

Updated On : 12 Apr 2017 | 4:09 AM IST

Proposed biosimilar is one of the six products co-developed by Mylan and Biocon for global market

Updated On : 17 Feb 2017 | 5:18 PM IST

Lawmakers were trying to determine whether Mylan made more money on EpiPen than warranted from state Medicaid programmes

Updated On : 09 Oct 2016 | 1:15 PM IST

Democratic Presidential candidate Hillary Clinton had criticised EpiPen's high price

Updated On : 25 Aug 2016 | 7:04 PM IST